Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure | EMBO Molecular Medicine
Development of macitentan for the treatment of pulmonary arterial hypertension - Selej - 2015 - Annals of the New York Academy of Sciences - Wiley Online Library
Pulmonary Arterial Hypertension: New Insights Into the Optimal Role of Current and Emerging Prostacyclin Therapies
Relationship between ET-1 and RAS. Bosentan treatment increased the... | Download Scientific Diagram
Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis | Journal of Medicinal Chemistry
Electronic Medical Records – What I've Learned As A Hospital Medical Director
Ofev, INN-Nintedanib
Effects of bosentan, an edothelin receptor antagonist, on bile salt export pump and multidrug resistance-associated protein 2 | Request PDF
Comparative effectiveness of oral prostacyclin pathway drugs on hospitalization in patients with pulmonary hypertension in the United States: a retrospective database analysis - John W. McConnell, Yuen Tsang, Janis Pruett, William Drake
Frontiers | Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure
Fibrogenic Disorders in Human Diseases: From Inflammation to Organ Dysfunction | Journal of Medicinal Chemistry
Physiologically based pharmacokinetic modeling of tadalafil to inform pediatric dose selection in children with pulmonary arteri
Reproducing human and cross-species drug toxicities using a Liver-Chip | Science Translational Medicine
Endothelin | Pharmacological Reviews
NEW ZEALAND DATA SHEET TRACLEER®
Frontiers | Structural and Functional Diversity of Animal Toxins Interacting With GPCRs
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure
Reproducing human and cross-species drug toxicities using a Liver-Chip | Science Translational Medicine
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure | EMBO Molecular Medicine
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure | EMBO Molecular Medicine
Endothelin‐1 in the pathophysiology of obesity and insulin resistance - Jenkins - 2020 - Obesity Reviews - Wiley Online Library
